The U.S. Food and Drug Administration (FDA) has approved the cell therapy Aucatzyl (obecabtagene autoleucel) to treat adults with relapsed…
Articles by Marisa Wexler, MS
The U.S. Food and Drug Administration (FDA) has granted orphan drug designation to MB-108, an experimental virus-based therapy that…
Johnson & Johnson (J&J) is asking regulatory authorities in the European Union to approve a combination treatment based on…
A single infusion of the CAR T-cell therapy Carvykti (ciltacabtagene autoleucel) was sufficient to control disease activity in most…
Arcellx and Kite Pharma are planning to launch a Phase 3 clinical trial, dubbed iMMagine-3, to…
At its 15th annual gala, held in New York City this April, the International Myeloma Foundation (IMF) raised more…
A dysregulated immune response against viruses that cause hepatitis may lead to some cases of multiple myeloma (MM) —…
Adding Darzalex Faspro (daratumumab and hyaluronidase) — a subcutaneous or under-the-skin formulation of Darzalex (daratumumab) — to a standard…
The U.S. Food and Drug Administration (FDA) is delaying its review of an application that seeks to allow the cell…
A committee of the European Medicines Agency (EMA) has recommended that Elrexfio (elranatamab) — a therapy already in use…